ABLATION CATHETER, RENAL DENERVATION
Report
- Report Number
- 3010024164-2024-00001
- Event Type
- Injury
- Date Received
- April 4, 2024
- Date of Event
- January 18, 2024
- Report Date
- March 13, 2024
- Manufacturer
- RECOR MEDICAL, INC.
- Product Code
- QYI
- PMA / PMN Number
- P220023
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- SP
- Reporter Occupation
- OTHER
- Health Professional
- N
Narratives
FOLLOW UP TO INCLUDE MANUFACTURER INFORMATION IN SECTION D3. THIS SECTION WAS INADVERTANTLY LEFT BLANK IN THE INITIAL SUBMISSION.
THIS IS OUR FIRST ELECTRONIC MDR SUBMISSION AND THE REPORT WAS DELAYED DUE TO THE SIGNUP PROCESS. WE MAILED A HARD COPY TO FDA ON MARCH 13, 2024 WHICH WAS REJECTED.
THERE IS NO INDICATION OF ANY FAILURE OF THE DEVICE. IN ADDITION, THERE IS NO INDICATION OF ANY MISUSE OF THE DEVICE. EVENT: POST PROCEDURAL HEMATOMA. A 64-YEAR-OLD FEMALE PATIENT WAS SUCCESSFULLY TREATED WITH URDN PROCEDURE ON BILATERAL RENAL ARTERIES ON (B)(6) 2024. ON (B)(6) 2024, THREE DAYS FOLLOWING THE PROCEDURE, PATIENT HAD LOWER ABDOMINAL PAIN. CT OF THE ABDOMEN AND PELVIS WAS PERFORMED WHICH REVEALED INTRAPARENCHYMAL AND SUBCAPSULAR HEMATOMAS OF THE RIGHT KIDNEY AND POSTERIOR PARARENAL FASCIA WITHOUT EVIDENCE OF ACTIVE BLEEDING. THE PATIENT WAS ADMITTED TO THE HOSPITAL ON (B)(6) 2024. SUPPORTIVE TREATMENT WAS GIVEN. ON (B)(6) 2024, PATIENT'S CONDITION WAS IMPROVED AND PATIENT WAS DISCHARGED UNDER STABLE CONDITION.
THERE IS NO INDICATION OF ANY FAILURE OF THE DEVICE. IN ADDITION, THERE IS NO INDICATION OF ANY MISUSE OF THE DEVICE. EVENT: POST PROCEDURAL HEMATOMA. A 64-YEAR-OLD FEMALE PATIENT WAS SUCCESSFULLY TREATED WITH URDN PROCEDURE ON BILATERAL RENAL ARTERIES ON (B)(6) 2024. ON (B)(6) 2024, THREE DAYS FOLLOWING THE PROCEDURE, PATIENT HAD LOWER ABDOMINAL PAIN. CT OF THE ABDOMEN AND PELVIS WAS PERFORMED WHICH REVEALED INTRAPARENCHYMAL AND SUBCAPSULAR HEMATOMAS OF THE RIGHT KIDNEY AND POSTERIOR PARARENAL FASCIA WITHOUT EVIDENCE OF ACTIVE BLEEDING. THE PATIENT WAS ADMITTED TO THE HOSPITAL ON (B)(6) 2024. SUPPORTIVE TREATMENT WAS GIVEN. ON (B)(6) 2024, PATIENT'S CONDITION WAS IMPROVED AND PATIENT WAS DISCHARGED UNDER STABLE CONDITION.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 86630 | ABLATION CATHETER, RENAL DENERVATION | QYI | RECOR MEDICAL, INC. |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 64 YR | Female | Hospitalization | AAS| AAS| ALDACTONE| ALDACTONE| ATENOLOL| ATENOLOL| ATOZET| ATOZET| CAPENON HCT| CAPENON HCT| CARDURAN| CARDURAN| CLOPIDOGREL| CLOPIDOGREL| HYDRALAZINE| HYDRALAZINE| RECOR PARADISE RENAL DENERVATION SYSTEM| RECOR PARADISE RENAL DENERVATION SYSTEM| TOUJEO| TOUJEO |